South Korea · Delayed Price · Currency is KRW PeopleBio Statistics
Total Valuation
PeopleBio has a market cap or net worth of KRW 24.46 billion. The enterprise value is 34.87 billion.
| Market Cap | 24.46B |
| Enterprise Value | 34.87B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PeopleBio has 24.26 million shares outstanding. The number of shares has increased by 0.50% in one year.
| Current Share Class | 24.26M |
| Shares Outstanding | 24.26M |
| Shares Change (YoY) | +0.50% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 9.13% |
| Owned by Institutions (%) | n/a |
| Float | 21.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.52 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 0.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.46, with a Debt / Equity ratio of 0.44.
| Current Ratio | 0.46 |
| Quick Ratio | 0.28 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.30 |
| Interest Coverage | -4.02 |
Financial Efficiency
Return on equity (ROE) is -68.73% and return on invested capital (ROIC) is -25.15%.
| Return on Equity (ROE) | -68.73% |
| Return on Assets (ROA) | -19.91% |
| Return on Invested Capital (ROIC) | -25.15% |
| Return on Capital Employed (ROCE) | -36.22% |
| Weighted Average Cost of Capital (WACC) | 10.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.08 |
| Inventory Turnover | 1.42 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.78% in the last 52 weeks. The beta is 0.55, so PeopleBio's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -60.78% |
| 50-Day Moving Average | 1,180.74 |
| 200-Day Moving Average | 1,326.51 |
| Relative Strength Index (RSI) | 42.28 |
| Average Volume (20 Days) | 592,168 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PeopleBio had revenue of KRW 2.87 billion and -14.90 billion in losses. Loss per share was -681.91.
| Revenue | 2.87B |
| Gross Profit | -136.43M |
| Operating Income | -11.48B |
| Pretax Income | -11.71B |
| Net Income | -14.90B |
| EBITDA | -10.16B |
| EBIT | -11.48B |
| Loss Per Share | -681.91 |
Balance Sheet
The company has 2.99 billion in cash and 13.11 billion in debt, with a net cash position of -10.12 billion or -417.05 per share.
| Cash & Cash Equivalents | 2.99B |
| Total Debt | 13.11B |
| Net Cash | -10.12B |
| Net Cash Per Share | -417.05 |
| Equity (Book Value) | 29.77B |
| Book Value Per Share | 1,334.07 |
| Working Capital | -8.56B |
Cash Flow
In the last 12 months, operating cash flow was -5.49 billion and capital expenditures -213.61 million, giving a free cash flow of -5.70 billion.
| Operating Cash Flow | -5.49B |
| Capital Expenditures | -213.61M |
| Depreciation & Amortization | 1.32B |
| Net Borrowing | 398.19M |
| Free Cash Flow | -5.70B |
| FCF Per Share | -234.97 |
Margins
| Gross Margin | -4.75% |
| Operating Margin | -399.81% |
| Pretax Margin | -407.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PeopleBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.50% |
| Shareholder Yield | -0.50% |
| Earnings Yield | -60.92% |
| FCF Yield | -23.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 23, 2023. It was a forward split with a ratio of 1.2.
| Last Split Date | Oct 23, 2023 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
PeopleBio has an Altman Z-Score of -2.5 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.5 |
| Piotroski F-Score | 1 |